Email Updates

You are here

CDC 4370/ Bangkok TFV Study

Status
Completed
Phase
III
II
Principal Investigator(s)
Kachit Choopanya, MD
Objective


To assess the safety and efficacy of daily tenofovir to prevent parenteral HIV infection among injection drug users (IDU) in Thailand. IDU was defined as individuals who reported substance use in the past year from the time they were screened.

Key results: There was a 49% reduction in HIV infection rate among IDU in Thailand with Daily oral TDF.

Last update August 10, 2022

June 2005
October 2014
Date of Enrollment Completion
July 1, 2013
Enrollment
2 413
20
Years
60
Years
Population
Injecting drug users
Sites

Site(s) - Thailand

Thailand